VIR Q1 2019 Earnings — Vir Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

VIRVir Biotechnology, Inc.

$1B

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$17,000-99.3% YoY

Gross Profit

-$26M-152088.2% margin

Operating Income

-$31M-181000.0% margin

Net Income

-$29M-168647.1% margin

EPS (Diluted)

$-0.30

QoQ Revenue Growth

+183.3%

Cash Flow

Operating Cash Flow

-$29M

Free Cash Flow

-$33M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$0

Total Liabilities

$0

Stockholders' Equity

$131M

Cash & Equivalents

-$98M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17,000	$2M	-99.3%
Gross Profit	-$26M	-$21M	-23.9%
Operating Income	-$31M	-$28M	-10.8%
Net Income	-$29M	-$28M	-2.3%